Articles published by Alumis Inc.

Alumis to Participate in Upcoming September Investor Conferences

September 03, 2024

From Alumis Inc.

Via GlobeNewswire

Tickers ALMS

Alumis Reports Second Quarter 2024 Financial Results and Highlights Recent Development and Corporate Achievements

August 13, 2024

From Alumis Inc.

Via GlobeNewswire

Tickers ALMS

Alumis Initiates ONWARD Phase 3 Clinical Program Evaluating ESK-001, an Oral TYK2 Inhibitor, in Moderate-to-Severe Plaque Psoriasis

July 29, 2024

From Alumis Inc.

Via GlobeNewswire

Tickers ALMS

Alumis Announces Initiation of Patient Dosing in Phase 2 Clinical Trial of ESK-001 for the Treatment of Plaque Psoriasis

September 28, 2022

From Alumis Inc.

Via Business Wire

Alumis Appoints Jörn Drappa M.D., Ph.D., as Chief Medical Officer and Roman G. Rubio, M.D., as Senior Vice President, Clinical Development and Translational Medicine

September 08, 2022

From Alumis Inc.

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Oil & Gas Journal starts where other industry publications stop. It delivers more than information; it delivers context, adding details the others leave out and combining them with analysis, commentary, industry trends, and statistics.

Newsletters

The top stories, industry insights and relevant research, assembled by our editors and delivered to your inbox.

Connect

http://www.facebook.com/ogjonline

https://www.linkedin.com/company/oil-&-gas-journal

http://twitter.com/ogjonline

Affiliated Brands

About Us
Advertise
Do Not Sell or Share
Privacy Policy
Terms & Conditions